Thread-Embedding Acupuncture for Functional and QoL Improvement in COPD Patients
Launched by INDONESIA UNIVERSITY · Apr 22, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether a treatment called thread-embedding acupuncture (TEA) can help improve the ability to exercise and overall quality of life for patients with chronic obstructive pulmonary disease (COPD). The study will compare the effects of TEA, combined with regular COPD treatment, to a placebo treatment that does not involve actual acupuncture. Researchers want to see if TEA helps patients walk further in six minutes and feel better overall, as measured by specific questionnaires over three months.
To be eligible for this study, participants must be between 18 and 70 years old and have stable COPD. They should not have certain health issues, like pregnancy or serious heart problems, and they should not have had recent acupuncture treatments. Participants will complete a walking test and answer questions about their health before receiving one session of either TEA or the placebo, followed by monthly check-ins for three months. This trial is currently not recruiting participants, but it aims to help find new ways to enhance the health and well-being of those living with COPD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female participants aged 18 to 70 years.
- • Body Mass Index (BMI) ≥18.5 kg/m².
- • Diagnosed with stable chronic obstructive pulmonary disease (COPD) based on GOLD criteria.
- • Willing to participate in the study until completion and has signed informed consent.
- Exclusion Criteria:
- • Pregnant women.
- • Presence of tumors, wounds, inflammation, or skin infection at the needling area.
- • Blood disorders or use of blood-thinning medications (antiplatelets or anticoagulants) with INR \> 2.0.
- • Uncontrolled heart disease or diabetes.
- • Capillary blood glucose level ≥200 mg/dL (measured using glucometer).
- • History of malignancy, uncontrolled epilepsy, or psychiatric disorders.
- • Known allergy to stainless steel or polydioxanone (PDO) thread.
- • Undergoing acupuncture therapy within the last 2 weeks or thread-embedding acupuncture (TEA) within the last 6 months.
About Indonesia University
Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jakarta Pusat, Dki Jakarta, Indonesia
Patients applied
Trial Officials
KPEK FKUI-RSCM
Principal Investigator
The Health Research Ethics Commitee - Faculty of Medicine Universitas Indonesia and Dr. Cipto Mangunkusumo National Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported